📋 THERIVA BIOLOGICS, INC. (TOVX) - Clinical Trial Update
Filing Date: 2026-04-17
Accepted: 2026-04-17 16:15:27
Event Type: Clinical Trial Update
Event Details:
THERIVA BIOLOGICS, INC. (TOVX) Announces Clinical Trial Update
THERIVA BIOLOGICS, INC. (TOVX) provided an update on its clinical development programs.
Clinical Development Highlights:
Drug Program: held, diseases
Diseases/Conditions: San Diego, areas of high unmet need
Clinical Stage: clinical trial, Clinical Trial
Collaboration: Metastatic Pancreatic Cancer
🔬 Clinical Development Pipeline (THERIVA BIOLOGICS, INC.):
Product
Type
Development Stage
Therapeutic Area
Source
Nab-paclitaxel
DRUG
Phase PHASE2
Pancreatic Adenocarcinoma
ClinicalTrials.gov
SYN-004, Ribaxamase or Placebo
BIOLOGICAL
Phase PHASE1
Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant
ClinicalTrials.gov
VCN-01
GENETIC
Phase PHASE2
Pancreatic Adenocarcinoma
ClinicalTrials.gov
Period 2 - Treatment Sequence AC
DRUG
Phase PHASE1
Healthy Volunteers
ClinicalTrials.gov
Gemcitabine
DRUG
Phase PHASE2
Pancreatic Adenocarcinoma
ClinicalTrials.gov
SYN-004
DRUG
Phase PHASE2
Clostridium Difficile
ClinicalTrials.gov
Abraxane®
DRUG
Phase PHASE1
Pancreatic Adenocarcinoma
ClinicalTrials.gov
Durvalumab
BIOLOGICAL
Phase PHASE1
Head and Neck Neoplasms
ClinicalTrials.gov
huCART-meso Cells
BIOLOGICAL
Phase PHASE1
Pancreatic Cancer
ClinicalTrials.gov
SYN-020 Delayed Release Capsule
DRUG
Phase PHASE1
Enteritis Caused by Radiation
ClinicalTrials.gov
Placebo
DRUG
Phase PHASE2
Irritable Bowel Syndrome With Constipation
ClinicalTrials.gov
SYN-010 42 mg
DRUG
Phase PHASE2
Irritable Bowel Syndrome With Constipation
ClinicalTrials.gov
SYN-010 21 mg
DRUG
Phase PHASE2
Irritable Bowel Syndrome With Constipation
ClinicalTrials.gov
SYN-010
DRUG
Phase PHASE2
Irritable Bowel Syndrome With Constipation (IBS-C)
📋 THERIVA BIOLOGICS, INC. (TOVX) - Clinical Trial Update
Filing Date: 2026-04-17
Accepted: 2026-04-17 16:15:27
Event Type: Clinical Trial Update
Event Details:
🔬 Clinical Development Pipeline (THERIVA BIOLOGICS, INC.):
💼 Business Developments:
Structured Data: